Home » Newsletters » BioWorld Science

BioWorld Science

July 29, 2014

View Archived Issues

Philips to acquire Unisensor to enhance point-of-care diagnostic business

Celsion reports data from DIGNITY and HEAT studies

OJSC Pharmstandard and Millhouse acquire stakes in Biocad Holding

Otsuka Pharmaceutical signs collaboration agreement with Horizon CombinatoRx

Patient with congestive heart failure treated with combination stem cell treatment

Parnell in-licenses Cimtech compounds for bone and dermal regeneration

GlaxoSmithKline reviews pipeline progress of second quarter 2014

Phase III study of S-1 in hepatocellular carcinoma does not meet primary endpoint

Lpath reports interim data from phase IIa study of Asonep

Decoy Biosystems patents new bacterial agents for cancer

Scientists at Eli Lilly patent novel agents for insomnia

Novel SHIP-1 modulators disclosed by Aquinox Pharmaceuticals

Novel RNA-based transcriptional gene silencing strategy inhibits HIV-1 activation in vitro

Novo Nordisk receives positive CHMP opinion on Xultophy

Envarsus receives European approval for both kidney and liver transplant patients

Kinex Pharmaceuticals confirms FDA allowance of IND application for KX2-391 ointment

Discovery of new HIV-1 Gag mutations linked to protease inhibitor resistance

FDA clears IND for LOR-253 in patients with AML, MDS and other blood cancers

AcelRx Pharmaceuticals receives complete response letter from FDA for Zalviso

Simbrinza approved in the E.U. to treat glaucoma

Retrophin submits proposal to acquire Clinuvel Pharmaceuticals

Researchers in China present new proto-oncogene c-Abl inhibitors for cancer

Imbruvica granted full approval in U.S. for chronic lymphocytic leukemia

Arena Pharmaceuticals designs novel H3 receptor antagonists

Eli Lilly synthesizes novel autotaxin inhibitors for pain

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...